X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (425) 425
humans (355) 355
animals (225) 225
iron (224) 224
siderophores - therapeutic use (197) 197
deferoxamine - therapeutic use (187) 187
siderophores (178) 178
iron - metabolism (173) 173
microbiology (169) 169
male (153) 153
siderophore (146) 146
deferoxamine (123) 123
female (122) 122
virulence (116) 116
biochemistry & molecular biology (99) 99
pharmacology & pharmacy (98) 98
bacteria (94) 94
siderophores - pharmacology (90) 90
mice (80) 80
siderophores - metabolism (73) 73
antibiotics (71) 71
adult (70) 70
deferoxamine - pharmacology (70) 70
desferrioxamine (63) 63
pathogens (62) 62
escherichia-coli (60) 60
health aspects (59) 59
infections (59) 59
iron chelating agents - therapeutic use (59) 59
research (59) 59
rats (58) 58
proteins (57) 57
adolescent (56) 56
disease models, animal (55) 55
biosynthesis (54) 54
infectious diseases (53) 53
pseudomonas-aeruginosa (52) 52
chemistry, medicinal (51) 51
anti-bacterial agents - pharmacology (50) 50
metabolism (50) 50
child (49) 49
identification (49) 49
siderophores - chemistry (49) 49
hematology (48) 48
analysis (47) 47
life sciences (46) 46
ferritins - blood (45) 45
biotechnology & applied microbiology (44) 44
molecular structure (44) 44
research article (44) 44
immunology (42) 42
microbial sensitivity tests (42) 42
multidisciplinary sciences (42) 42
oxidative stress (42) 42
iron overload - drug therapy (41) 41
physiological aspects (41) 41
biology (39) 39
bacterial proteins - metabolism (38) 38
pseudomonas aeruginosa (38) 38
siderophore biosynthesis (38) 38
beta-thalassemia - drug therapy (37) 37
transport (37) 37
deferoxamine - administration & dosage (36) 36
siderophores - administration & dosage (36) 36
chelation therapy (35) 35
siderophores - biosynthesis (35) 35
thalassemia (35) 35
drug therapy, combination (34) 34
genes (34) 34
infection (34) 34
deferiprone (33) 33
gene expression (33) 33
growth (33) 33
medicine (33) 33
bacterial proteins - genetics (32) 32
pyridones - therapeutic use (32) 32
chelation (31) 31
enzymes (31) 31
homeostasis (31) 31
bacterial infections (30) 30
deferoxamine - adverse effects (30) 30
therapy (30) 30
time factors (30) 30
treatment outcome (30) 30
biofilms (29) 29
fungi (29) 29
iron chelating agents - pharmacology (29) 29
resistance (29) 29
siderophores - adverse effects (29) 29
drug resistance (28) 28
gram-negative bacteria (28) 28
iron overload (28) 28
microorganisms (28) 28
middle aged (28) 28
pathogenesis (28) 28
toxicity (28) 28
biochemistry, general (27) 27
care and treatment (27) 27
drug resistance in microorganisms (27) 27
in-vitro activity (27) 27
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (714) 714
German (5) 5
Spanish (4) 4
French (2) 2
Chinese (1) 1
Italian (1) 1
Japanese (1) 1
Romanian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


DEUTSCHES ARZTEBLATT INTERNATIONAL, ISSN 1866-0452, 05/2018, Volume 115, Issue 20-21, pp. 345 - 345
... in therapeutic decision-making, particularly because of the high frequency of co-resistance. Methods: This review is based on pertinent... 
ACINETOBACTER-BAUMANNII | MEDICINE, GENERAL & INTERNAL | URINARY-TRACT-INFECTIONS | ENTEROBACTERIACEAE INFECTIONS | IMIPENEM-CILASTATIN | COMPLICATED INTRAABDOMINAL INFECTIONS | CEFTAZIDIME-AVIBACTAM | DOUBLE-BLIND | BETA-LACTAMASE INHIBITOR | KLEBSIELLA-PNEUMONIAE | SIDEROPHORE CEPHALOSPORIN | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Escherichia coli - drug effects | Humans | Cephalosporins - standards | Piperacillin - standards | Cephalosporins - therapeutic use | Piperacillin - pharmacology | Carbapenems - pharmacology | Colistin - pharmacology | Pseudomonas aeruginosa - pathogenicity | Escherichia coli - pathogenicity | Fluoroquinolones - standards | Colistin - therapeutic use | Cephalosporins - pharmacology | Tigecycline - therapeutic use | Fosfomycin - therapeutic use | Fosfomycin - pharmacology | Fluoroquinolones - therapeutic use | Pseudomonas aeruginosa - drug effects | Carbapenems - standards | Gram-Negative Bacteria - drug effects | Drug Therapy, Combination - methods | Carbapenems - therapeutic use | Klebsiella pneumoniae - pathogenicity | Fluoroquinolones - pharmacology | Aminoglycosides - pharmacology | Carbapenem-Resistant Enterobacteriaceae - drug effects | Tigecycline - pharmacology | Ceftazidime - therapeutic use | Drug Therapy, Combination - standards | Germany | Aminoglycosides - therapeutic use | Piperacillin - therapeutic use | Review
Journal Article
Journal Article
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 09/2016, Volume 115, Issue 7, pp. 805 - 813
Journal Article
International journal of cancer, ISSN 0020-7136, 2013, Volume 133, Issue 7, pp. 1732 - 1742
Journal Article
Journal Article
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 02/2011, Volume 133, Issue 7, pp. 2076 - 2079
... pathogen-selective therapeutic agents in which the iron component of the delivery vehicle also participates in triggering the antibiotic activity can be generated. The result is that one appropriate conjugate has potent and selective activity against two of the most deadly diseases in the world. 
DRUG | SIDEROPHORES | MECHANISM | IRON CHELATORS | ANALOGS | AGENTS | CANCER | CHEMISTRY, MULTIDISCIPLINARY | Iron Chelating Agents - therapeutic use | Oxazoles - metabolism | Iron Chelating Agents - metabolism | Iron Chelating Agents - chemistry | Oxazoles - chemistry | Artemisinins - therapeutic use | Antitubercular Agents | Mycobacterium tuberculosis | Tuberculosis - drug therapy | Drug Design | Artemisinins - metabolism | Molecular Structure | Malaria - drug therapy | Oxazoles - therapeutic use | Artemisinins - chemistry | Drug resistance in microorganisms | Chemical synthesis | Analysis
Journal Article